Blood test co Sight Diagnostics raises $28m
09:26 EST 23 Dec 2018 |
Globes
The Israeli company's test for malaria is being marketing in developing countries.
Original Article: Blood test co Sight Diagnostics raises $28m
More From BioPortfolio on "Blood test co Sight Diagnostics raises $28m"